Literature DB >> 15618947

Overview of diagnosis and drug treatments of anxiety disorders.

David J Nutt1.   

Abstract

Anxiety disorders are common and often disabling. They fall into five main categories: panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder and posttraumatic stress disorder, each of which have characteristic symptoms and cognitions. All anxiety disorders respond to drugs and psychological treatments. This review will focus on drug treatments. Recent research has emphasized the value of antidepressants especially the selective serotonin reuptake inhibitors, benzodiazepines, and related sedative-like compounds. The common co-existence of depression with all of the anxiety disorders means that the selective serotonin reuptake inhibitors are now generally considered to be the first-line treatments but the benzodiazepines have some utility especially in promoting sleep and working acutely to reduce extreme distress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618947     DOI: 10.1017/s1092852900009901

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  40 in total

1.  Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure.

Authors:  Bradford D Fischer; Stephanie C Licata; Rahul V Edwankar; Zhi-Jian Wang; Shengming Huang; Xiaohui He; Jianming Yu; Hao Zhou; Edward M Johnson; James M Cook; Roman Furtmüller; Joachim Ramerstorfer; Werner Sieghart; Bryan L Roth; Samarpan Majumder; James K Rowlett
Journal:  Neuropharmacology       Date:  2010-08-18       Impact factor: 5.250

Review 2.  Prescription privileges for psychologists: a comprehensive review and critical analysis of current issues and controversies.

Authors:  Kim L Lavoie; Silvana Barone
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors.

Authors:  James K Rowlett; Snjezana Lelas; Walter Tornatzky; Stephanie C Licata
Journal:  Psychopharmacology (Berl)       Date:  2005-12-24       Impact factor: 4.530

Review 4.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

5.  Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study.

Authors:  Karine Madsen; Mette T Haahr; Lisbeth Marner; Sune H Keller; William F Baaré; Claus Svarer; Steen G Hasselbalch; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-02       Impact factor: 6.200

Review 6.  A Review of Alprazolam Use, Misuse, and Withdrawal.

Authors:  Nassima Ait-Daoud; Allan Scott Hamby; Sana Sharma; Derek Blevins
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

Review 7.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

8.  Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors.

Authors:  Anne Teissier; Alexei Chemiakine; Benjamin Inbar; Sneha Bagchi; Russell S Ray; Richard D Palmiter; Susan M Dymecki; Holly Moore; Mark S Ansorge
Journal:  Cell Rep       Date:  2015-11-19       Impact factor: 9.423

9.  5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia.

Authors:  Christiaan H Vinkers; Ruud van Oorschot; S Mechiel Korte; Berend Olivier; Lucianne Groenink
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

Review 10.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.